Combioxin SA announcement: The Lancet Infectious Diseases publishes the first clinical results with CAL02
Combioxin SA announcement: The Lancet Infectious Diseases published today the first clinical results with CAL02, a first-in-class drug, in severe pneumonia patients, showing safety and consistent superiority over placebo in all efficacy parameters (Online First).
Full PR available here